{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:14:25Z","timestamp":1778696065462,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KO 1557\/14-1"],"award-info":[{"award-number":["KO 1557\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003484","name":"Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf","doi-asserted-by":"publisher","award":["9772681"],"award-info":[{"award-number":["9772681"]}],"id":[{"id":"10.13039\/501100003484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.biopha.2019.109797","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T16:38:34Z","timestamp":1577119114000},"page":"109797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cyclooxygenase activity in bradykinin-induced dermal extravasation. A study in mice and humans"],"prefix":"10.1016","volume":"123","author":[{"given":"Ehsan","family":"Gholamreza-Fahimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Bisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7641-7118","authenticated-orcid":false,"given":"Janina","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Stra\u00dfen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Krybus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farbod","family":"Khosravani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas K.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0628-0608","authenticated-orcid":false,"given":"Jens","family":"Greve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Bas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f6ren","family":"Twarock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6911-6990","authenticated-orcid":false,"given":"Georg","family":"Kojda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2019.109797_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.57.1.2","article-title":"International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences","volume":"57","author":"Leeb-Lundberg","year":"2005","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2019.109797_bib0010","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1398-9995.2007.01427.x","article-title":"Non-allergic angioedema. Role of bradykinin","volume":"62","author":"Bas","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.biopha.2019.109797_bib0015","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2019.109797_bib0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12016-016-8540-0","article-title":"Bradykinin: inflammatory product of the coagulation system","volume":"51","author":"Hofman","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.biopha.2019.109797_bib0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.moo.0000193202.85837.7d","article-title":"Evaluation and management of angioedema of the head and neck","volume":"14","author":"Bas","year":"2006","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.biopha.2019.109797_bib0030","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(11)60935-5","article-title":"Hereditary angio-oedema","volume":"379","author":"Longhurst","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.biopha.2019.109797_bib0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11906-018-0859-x","article-title":"ACE inhibitor-induced angioedema: a review","volume":"20","author":"Kostis","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.biopha.2019.109797_bib0040","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.anai.2014.09.003","article-title":"Angioedema deaths in the United States, 1979\u20132010","volume":"113","author":"Kim","year":"2014","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.biopha.2019.109797_bib0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1378\/chest.126.2.400","article-title":"Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital","volume":"126","author":"Sondhi","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2019.109797_bib0050","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","article-title":"A randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Bas","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2019.109797_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2017.03.003","article-title":"Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema","volume":"5","author":"Sinert","year":"2017","journal-title":"J. Allergy Clin. Immunol. In practice"},{"issue":"5","key":"10.1016\/j.biopha.2019.109797_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.06.037","article-title":"Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema","volume":"142","author":"Hubers","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2019.109797_bib0065","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI200214211","article-title":"Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor","volume":"109","author":"Han","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2019.109797_bib0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.immuni.2011.02.008","article-title":"Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo","volume":"34","author":"Oschatz","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2019.109797_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1439-0272.2003.00533.x","article-title":"Structure and signalling pathways of kinin receptors","volume":"35","author":"Blaukat","year":"2003","journal-title":"Andrologia"},{"key":"10.1016\/j.biopha.2019.109797_bib0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/46816","article-title":"Cytochrome P450 2C is an EDHF synthase in coronary arteries","volume":"401","author":"Fisslthaler","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2019.109797_bib0085","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1073\/pnas.93.23.13176","article-title":"Elevated blood pressures in mice lacking endothelial nitric oxide synthase","volume":"93","author":"Shesely","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2019.109797_bib0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0008-6363(98)00315-0","article-title":"Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control","volume":"42","author":"Kojda","year":"1999","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.biopha.2019.109797_bib0095","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2019.109797_bib0100","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109797_bib0105","first-page":"228","article-title":"Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs","volume":"118","author":"Miles","year":"1952","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.biopha.2019.109797_bib0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0162-3109(99)00150-2","article-title":"Pharmacological characterization of RMP-7, a novel bradykinin agonist in smooth muscle","volume":"45","author":"Shimuta","year":"1999","journal-title":"Immunopharmacology"},{"issue":"10","key":"10.1016\/j.biopha.2019.109797_bib0115","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/bph.14166","article-title":"The role of bradykinin receptor type 2 in spontaneous extravasation in mice skin: implications for non-allergic angio-oedema","volume":"175","author":"Bisha","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109797_bib0120","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cvr\/cvq139","article-title":"The NO cascade, eNOS location, and microvascular permeability","volume":"87","author":"Duran","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2019.109797_bib0125","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.274.35.25130","article-title":"Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1\/KDR activation of c-Src","volume":"274","author":"He","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2019.109797_bib0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cardiores.2003.12.028","article-title":"Nitric oxide: inhibitory effects on endothelial cell calcium signaling, prostaglandin I2 production and nitric oxide synthase expression","volume":"62","author":"Takeuchi","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2019.109797_bib0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/246215a0","article-title":"Prostaglandins as potentiators of increased vascular permeability in inflammation","volume":"246","author":"Williams","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2019.109797_bib0140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/270530a0","article-title":"Role of prostaglandin-mediated vasodilatation in inflammation","volume":"270","author":"Williams","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2019.109797_bib0145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0006-2952(86)90351-5","article-title":"Suppression of inflammatory oedema by ibuprofen involving a mechanism independent of cyclo-oxygenase inhibition","volume":"35","author":"Rampart","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109797_bib0150","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0024-3205(98)00176-3","article-title":"Stimulated prostaglandin E2 release from rat skin, in vitro","volume":"62","author":"Sauer","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2019.109797_bib0155","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/41780","article-title":"Altered pain perception and inflammatory response in mice lacking prostacyclin receptor","volume":"388","author":"Murata","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2019.109797_bib0160","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2019.109797_bib0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pharmthera.2004.06.003","article-title":"Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation","volume":"103","author":"Hata","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2019.109797_bib0170","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chem. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2019.109797_bib0175","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrrheum.2013.126","article-title":"Annexin A1: potential for glucocorticoid sparing in RA","volume":"9","author":"Yang","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2019.109797_bib0180","doi-asserted-by":"crossref","first-page":"8298","DOI":"10.1021\/jm101094p","article-title":"1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2alpha: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability","volume":"53","author":"Bovens","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109797_bib0185","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2019.109797_bib0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","article-title":"Vascular permeability, vascular hyperpermeability and angiogenesis","volume":"11","author":"Nagy","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.biopha.2019.109797_bib0195","doi-asserted-by":"crossref","first-page":"e2239","DOI":"10.7717\/peerj.2239","article-title":"Equivalent intraperitoneal doses of ibuprofen supplemented in drinking water or in diet: a behavioral and biochemical assay using antinociceptive and thromboxane inhibitory dose-response curves in mice","volume":"4","author":"Salama","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.biopha.2019.109797_bib0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/all.12556","article-title":"Stability of murine bradykinin type 2 receptor despite treatment with NO, bradykinin, icatibant, or C1-INH","volume":"70","author":"Khosravani","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.biopha.2019.109797_bib0205","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1590\/S0100-879X2007000500007","article-title":"Functional expression of kinin B1 and B2 receptors in mouse abdominal aorta","volume":"40","author":"Felipe","year":"2007","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.biopha.2019.109797_bib0210","first-page":"543","article-title":"Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm","volume":"412","author":"Benjamin","year":"1989","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.biopha.2019.109797_bib0215","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2125.1994.tb04358.x","article-title":"Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm","volume":"38","author":"Cockcroft","year":"1994","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219354198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219354198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:37:05Z","timestamp":1778693825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219354198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":43,"alternative-id":["S0753332219354198"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109797","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclooxygenase activity in bradykinin-induced dermal extravasation. A study in mice and humans","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109797"}}